What is DARE's dilution risk score?

DARE has a latest available DilutionScore record of 55/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for DARE, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for DARE?

DilutionWatch tracks 25 SEC filing types for DARE including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect DARE shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For DARE, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for DARE tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for DARE. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

DARE Dilution Risk Score: 55/100 (HIGH)

Score Breakdown

📋 Offering Ability

46

💰 Cash Runway

85

📊 Float Risk

10

⚠️ Warrant Exposure

15

🔄 Convertible Debt

40

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 25%

💰 Capital Raise model 35%

• Low cash runway: 4 months remaining

🔄 Reverse Split model est. 15%

• Only 4 months cash — financial pressure

📉 Score Deterioration model 15%

• Score climbed 5 points (worsening)

🔔 Track DARE — Get forecast alerts →

Market Data

Market Cap$33.40M

Shares Outstanding15.29M

Float13.70M

Cash$12.62M

Debt$10.5K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 50.8% shares (2026Q1 vs prior)

26 institutional holders · 1.49M shares

#1 VANGUARD CAPITAL MANAGEMENT LLC 924.6K shares

#2 GEODE CAPITAL MANAGEMENT, LLC 177.8K shares

#3 US BANCORP \DE\ 91.4K shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest839.8K

Days to Cover3.2

% of Float6.1%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2023-12-31

xbrl XBRL CONVERTIBLE 2018-12-31

8-K 8K EVENT 2026-04-20

8-K 8K EVENT 2026-04-13

8-K 8K EVENT 2026-03-17

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual DARE Dilution Snapshot

Daré Bioscience, Inc. (DARE) has a DilutionScore of 55/100, rated High dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 265,485.
Recent SEC activity tracked for DARE: 8-K on 2026-04-20; 8-K on 2026-04-13; 8-K on 2026-03-17.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.